Effect of ACV on VEGF and VEGFR2 expression in mouse renal tissues. by Hong Lu (58784)

“…(C) VEGF and VEGFR2 scores were calculated using the formula: IRS  =  SI (positive intensity) × PP (the percentage of positive cells) and were all significantly decreased after administration of ACV compared with saline group (means ± SD, n = 10), <i>*P<</i>0.05 vs. the saline group.…”

Intracellular VBNC cells maintain phenotype and viability in BMDMs. by Raffael Júnio Araújo de Castro (3875755)

“…<p>(<b>A</b>) Scheme depicting the cell treatments used to obtain BMDMs with different activation states. …”

Computational modeling of the bimodal distribution of RPs and altered parameters of the resting ion channels on the distribution of RPs. by Yuqin Yang (579353)

“…(<b><i>A</i></b>) The initial parameter inputs included simultaneously the four conductances with randomly generated variations around the means derived from (rounded) whole-cell measurements of single SMA cells. …”

Supplementary Material for: Na⁺-Leak Channel, Non-Selective (NALCN) Regulates Myometrial Excitability and Facilitates Successful Parturition by Reinl E.L. (5531735)

“…In human myometrium, the Na⁺ leak channel, non-selective (NALCN) contributes to a gadolinium-sensitive, Na⁺-dependent leak current. …”

Effects of CO₂ on diazotroph biomass δ¹⁵N by Dalin Shi (7966049)

“…Nitrogen isotope fractionation during this process is a key parameter for understanding the nitrogen cycle, however, relatively little is known about its regulatory mechanisms. …”

Gray matter alterations in the hippocampus and diffusion anisotropy with HYDI. by Madelaine Daianu (831026)

“…<p><b>A.</b> Transmission electron micrographs from 16 month old TgF344-AD rat hippocampus show numerous dystrophic neurites (DN, <i>left panel</i>), which are swollen at higher magnification (<i>right panel</i>). …”

CRAI with 5-Fu and Octreotide (Oct) attenuated serum parameters of pancreatitis. by Meng Tao Zhou (321534)

“…<p>Three treatment groups have lower serum levels of amylase activity, TNF-α and BUN as compared to the SAP group at different time points. The combined use of 5-Fu and Oct significantly decreased the levels of amylase activity as compared to single use of 5-Fu or Oct. …”

Wnt/β-catenin signaling pathway activation in conjunctival epithelium of airlift explant cultures. by Hui Lin (161703)

“…<p>β-catenin (column A) and phosphor-β-catenin (Ser-552, column B) staining were performed at different time points after airlifting culture. β-catenin mostly anchored to the cell membrane and showed very low expression levels in cytoplasm of normal conjunctival epithelium (D0). …”

Detrended cumulative plots based on data for the human chromosome 6. by Dorota Mackiewicz (31938)

“…<p><b>A</b>. Distribution of recombination hotspots along the chromosome. …”

Data Sheet 1_Development of subjective well-being in adolescents before and during the COVID-19 pandemic.pdf by Helene Eckert (20639243)

“…Data from N = 207 students (Grade 5 to 9) from two German schools were assessed on four measurement time points, three before and one after the onset of the pandemic. …”

Data Sheet 3_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 1_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 8_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 9_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 4_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 7_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 11_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 5_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 2_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”

Data Sheet 10_Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatoti... by Alessandro Colletta (1509928)

“…Secondary outcomes included LS changes measured via TE and ARFI. Additional end points included MELD-Na, MELD 3.0, CTP scores, hepatic decompensations, proteinuria, body mass index (BMI), hemoglobin A1c (Hb-A1c), blood glucose (BG).…”